Is Argenx a Good Biotech Stock to Buy for 2022?
Argenx (NASDAQ: ARGX) is a biotechnology stock that recently shot higher following FDA approval of its first drug. Efgartigimod is now the first drug of its kind approved to treat a debilitating disorder.
Rare drugs can generate blockbuster sales, but first-time drug launches can also be unpredictable. Let's look at reasons to buy Argenx now and weigh them against the apparent risks.
Image source: Getty Images.
Source Fool.com
